Biofrontera Inc.

MUN:AI10 Stock Report

Market Cap: €8.4m

Biofrontera Management

Management criteria checks 3/4

Biofrontera's CEO is Hermann Luebbert, appointed in May 2023, has a tenure of 1.67 years. total yearly compensation is $733.23K, comprised of 64.2% salary and 35.8% bonuses, including company stock and options. directly owns 0.2% of the company’s shares, worth €16.53K. The average tenure of the management team and the board of directors is 2.3 years and 3.2 years respectively.

Key information

Hermann Luebbert

Chief executive officer

US$733.2k

Total compensation

CEO salary percentage64.2%
CEO tenure1.7yrs
CEO ownership0.2%
Management average tenure2.3yrs
Board average tenure3.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Hermann Luebbert's remuneration changed compared to Biofrontera's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$13m

Jun 30 2024n/an/a

-US$14m

Mar 31 2024n/an/a

-US$23m

Dec 31 2023US$733kUS$471k

-US$20m

Sep 30 2023n/an/a

-US$26m

Jun 30 2023n/an/a

-US$23m

Mar 31 2023n/an/a

-US$14m

Dec 31 2022US$1mUS$475k

-US$640k

Sep 30 2022n/an/a

-US$12m

Jun 30 2022n/an/a

-US$26m

Mar 31 2022n/an/a

-US$29m

Dec 31 2021US$1mUS$18k

-US$38m

Compensation vs Market: Hermann's total compensation ($USD733.23K) is above average for companies of similar size in the German market ($USD462.70K).

Compensation vs Earnings: Hermann's compensation has been consistent with company performance over the past year.

CEO

Hermann Luebbert (68 yo)

1.7yrs

Tenure

US$733,225

Compensation

Dr. Prof. Hermann Luebbert, Ph.D. is a Co-Founder of Biofrontera AG and served as its Chief Executive Officer since 1997 until December 13, 2021 and served as its Chairman of Management Board since 2000 un...

Leadership Team

NamePositionTenureCompensationOwnership
Hermann Luebbert
CEO, President & Executive Chairman1.7yrsUS$733.23k0.20%
€ 16.5k
Eugene Leffler
Chief Financial Officer2.3yrsUS$441.68kno data
Erica Gates
Senior Director of Finance & Principal Accounting Officerno datano datano data
Jon Lyons
Vice President of Scientific & Medical Affairs2yrsno datano data
Alycia Torres
Vice President of Administration3yrsno datano data
Daniel Hakansson
General Counsel & Head of Compliance6yrsno datano data
Mark Baldyga
Vice President of Sales & Marketingno datano datano data

2.3yrs

Average Tenure

Experienced Management: AI10's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Hermann Luebbert
CEO, President & Executive Chairman9.8yrsUS$733.23k0.20%
€ 16.5k
John Borer
Independent Director3.2yrsUS$68.64kno data
Heikki Lanckriet
Director1.5yrsUS$19.36kno data
Kevin Weber
Independent Director2.8yrsUS$58.01kno data
Beth Hoffman
Independent Director3.2yrsUS$64.47kno data

3.2yrs

Average Tenure

66yo

Average Age

Experienced Board: AI10's board of directors are considered experienced (3.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 05:54
End of Day Share Price 2024/10/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biofrontera Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bruce JacksonBenchmark Company
Jonathan AschoffRoth MKM